Stephen Toovey
Direktor/Vorstandsmitglied bei 60 DEGREES PHARMACEUTICALS, INC.
Vermögen: 4 088 $ am 31.05.2024
Profil
Stephen Toovey is the founder of Shanghai Ark Biopharmaceutical Co., Ltd.
(founded in 2014).
He is currently working as an Independent Director at 60 Degrees Pharmaceuticals, Inc. since 2023.
Dr. Toovey obtained a doctorate degree from Ghent University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 17.05.2024 | 14 000 ( 0,12% ) | 4 088 $ | 31.05.2024 |
Aktive Positionen von Stephen Toovey
| Unternehmen | Position | Beginn |
|---|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Direktor/Vorstandsmitglied | 12.07.2023 |
Ehemalige bekannte Positionen von Stephen Toovey
| Unternehmen | Position | Ende |
|---|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
 Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Gründer | 01.01.2020 |
Ausbildung von Stephen Toovey
| Ghent University | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| 60 DEGREES PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Shanghai Ark Biopharmaceutical Co., Ltd.
Shanghai Ark Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Shanghai Ark Biopharmaceutical Co., Ltd. engages in biopharmaceutical services. It is a biopharmaceutical company which focuses on the discovery and development of novel therapeutics addressing unmet medical needs in respiratory and lung diseases. The firm’s product portfolio covering full disease cycle and patient segmentations, its drug candidates addresses a spectrum of acute and chronic respiratory and lung diseases. The company was founded by Jim Zhen WU and Wu Zheng Bo in April 2014 and is headquartered in Shanghai, China. | Health Technology |
